Speaker: Alison Moskowitz

Dr Alison Moskowitz Discusses Survival Disparities in Hodgkin Lymphoma

Dr Alison Moskowitz on the Importance of Patients Understanding Their Diagnosis, Treatment Options

Monoclonal Antibodies for Treatment in Hematologic Malignancies - Alison Moskowitz, MD

Academic Medical Education

Dr Alison Moskowitz: Standard of Care for Hodgkin Lymphoma Depends on Stage of Disease, Patient Age

Speaker spotlight with AusRock 2022 keynote speaker Dr Alison McQuillan

Dr. Moskowitz on PET-Adapted Therapy in Advanced Hodgkin Lymphoma

Debate: Best Second-line Approach to Induce Lymphoma Remission Prior to SCT? - Brentuximab

Personalized approaches to Hodgkin lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Pre-transplant salvage options: bringing conventional versus novel combinations to practice

Less aggressive approaches in relapsed/refractory Hodgkin lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

COVID-19 Politics and Policy Speaker Series with Alison Ciborowski

Changes in second-line lymphoma treatment

VJHemOnc – Video Journal of Hematology & HemOnc

Incorporating checkpoint-inhibitors into second-line CLL therapy

VJHemOnc – Video Journal of Hematology & HemOnc

The Ground Report,, On Real Media TT

Workers Rights 868

LAUNCH SCALE Speakers: Glenn Kelman, Alison Rosenthal & Paul Judge

This Week in Startups

Brentuximab for second-line lymphoma treatment

VJHemOnc – Video Journal of Hematology & HemOnc

Relapsed & refractory classic Hodgkin lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Webinar: Research Roadmap.

CutaneousLymphomaFnd

Pivots, Data and Growing a Tech Company - Dina Moskowitz

Non-Hodgkin Lymphoma - Webinar

Cancer Support Community